Experimental drug tested to control hepatitis b virus

NCT ID NCT02577029

Terminated Disease control Sponsor: Arrowhead Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study tested an experimental drug called ARC-520, given alone or with other standard hepatitis B medications, in people with chronic hepatitis B infection. The main goal was to see if the treatment could safely and significantly reduce the amount of hepatitis B virus in the blood. The trial involved 79 adult patients who had not been treated for hepatitis B before.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Site 1

Westmead, New South Wales, 2145, Australia
Research Site 10

Sofia, 1431, Bulgaria
Research Site 11

Sofia, 1463, Bulgaria
Research Site 12

Varna, 9020, Bulgaria
Research Site 13

Pleven, 5800, Bulgaria
Research Site 14

Hong Kong, China
Research Site 15

Seoul, 6273, South Korea
Research Site 16

Daegu, 41944, South Korea
Research Site 17

Busan, 49241, South Korea
Research Site 18

Seoul, 3080, South Korea
Research Site 19

Busan, South Korea
Research Site 2

Parkville, Victoria, 3052, Australia
Research Site 20

Seoul, South Korea
Research Site 21

Auckland, 1010, New Zealand
Research Site 23

Papatoetoe, Aukland, 2025, New Zealand
Research Site 24

Dunedin, Otago-Southland, New Zealand
Research Site 25

Chisinau, MD-2004, Moldova
Research Site 26

Changhua, 500, Taiwan
Research Site 27

Douliu, Yunlin County, 640, Taiwan
Research Site 28

Kaohsiung City, 807, Taiwan
Research Site 29

Bangkok, 10330, Thailand
Research Site 3

Camperdown, New South Wales, 2050, Australia
Research Site 30

Bangkok, 10400, Thailand
Research Site 31

Khon Kaen, 40002, Thailand
Research Site 32

Bangkok, 10400, Thailand
Research Site 33

Chiang Mai, 50200, Thailand
Research Site 34

Pathum Thani, 12120, Thailand
Research Site 4

Fitzroy, Victoria, 3065, Australia
Research Site 5

Darlinghurst, New South Wales, 2010, Australia
Research Site 6

Clayton, Victoria, 3168, Australia
Research Site 7

Nedlands, Washington, 6009, Australia
Research Site 8

Concord, New South Wales, 2139, Australia
Research Site 9

Adelaide, South Australia, 5000, Australia

Conditions

Explore the condition pages connected to this study.

HEPATITIS B HEPATITIS D